Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway
Open Access
- 14 October 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 22, 948-956
- https://doi.org/10.1016/j.omtn.2020.10.014
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem CellsInternational Journal of Molecular Sciences, 2013
- Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injuryBiochemical and Biophysical Research Communications, 2013
- Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolutionNature Reviews Immunology, 2013
- Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac DifferentiationCirculation Research, 2012
- Pervasive roles of microRNAs in cardiovascular biologyNature, 2011
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1Molecular Cell, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associationsBioinformatics, 2009
- Placenta-derived stem cells: new hope for cell therapy?Cytotechnology, 2008
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004